Роль дефензинів у неспецифічному захисті макроорганізму від інфекційних агентів при запальних захворюваннях порожнини рота і ротоглотки (огляд літератури)

Abstract

The purpose of the study was to analyze literature sources containing information about defensins, cysteine-rich cationic amphipathic peptides produced by circulating white blood cells and tissue cells. This review describes the antimicrobial, antiviral, anti-inflammatory and immunomodulatory properties of defensins, as well as their molecular and cellular interactions. These substances, which are present on the epithelium and body fluids, are active against bacteria, fungi and viruses, as well as produced by immune and epithelial cells. These natural antimicrobial cationic peptides play an important role in innate and adaptive immunity. Defensins are divided into alpha and beta families. Alpha-defensins (α-defensins) are found in neutrophils, macrophages and Paneth cells in the intestine. Beta-defensins (β-defensins) are secreted by most leukocytes and epithelial cells. Extensive antimicrobial activity and multifaceted immunomodulatory functions of defensins confirm their role in innate immunity as the main protective component of the human body against bacterial, viral and fungal infections. Thus, they are key effector molecules in protecting the organism from infection due to their broad-spectrum antimicrobial activity. Their common antimicrobial function is the formation of destructive pores in the membranes of pathogens, including enveloped viruses. Antiviral activity includes the direct effect of defensin on viral envelopes, glycoproteins and capsids. Binding and modulation of host cell surface receptors and disruption of intracellular signaling by defensins may also inhibit virus replication. These peptides block infection with enveloped and non-enveloped viruses by aggregating particles, blocking receptor binding, inhibiting virus penetration or depletion of particles, inhibiting stem cell signaling, or viral gene expression. In addition, defensins may function as chemokines to enhance and alter adaptive immune responses by exhibiting an indirect antiviral mechanism. Conclusion. However, sources of scientific information have shown that defensins attract immune cells and modulate adaptive immune responses. It has also been shown that defensins can both induce inflammation and suppress inflammatory responses by acting on certain cells through various mechanisms. Due to this, they can be used as one of the markers in the development of inflammatory diseases of the mouth and oropharynx. The main drugs that activate the production of defensins are probiotics, vitamin D and leukotriene B4. This expands the possibility of their use as a new class of non-toxic antimicrobials and immunomodulators